STAQ Pharma, Inc.: Drug Recall

Recall #D-0025-2026 · 10/09/2025

Class III: Low Risk

Recall Details

Recall Number: D-0025-2026
Classification: Class III
Product Type: Drug
Recalling Firm: STAQ Pharma, Inc.
Status: Ongoing
Date Initiated: 10/09/2025
Location: Denver, CO, United States
Voluntary/Mandated: Voluntary: Firm initiated

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Exp Date

Product Description

FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0102-05.

Distribution Pattern

Nationwide in the U.S.

Other Recalls by STAQ Pharma, Inc.

Class III: Low Risk 10/09/2025

Labeling: Incorrect or Missing Lot and/or Exp Date
Class III: Low Risk 10/09/2025

Labeling: Incorrect or Missing Lot and/or Exp Date
Class II: Risk 11/29/2023

STAQ Pharma Inc. received consumer complaints related to leaking bags and other potential bag concerns. Upon investigation, they determine the source of the issue was with the bag manufacturer who released bags Lot # 134142-001A which had failed internal QC tests for leaks.
Class I: Dangerous 02/03/2022

Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A
Class I: Dangerous 02/03/2022

Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A

View all recalls by STAQ Pharma, Inc. →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.